FDA Brief

Warning letters Drugs

FDA warning letter to

Ardil Comercial S.R.L.

High riskIssued Sep 22, 2021Posted Oct 5, 2021Center for Drug Evaluation and Research | CDER

FDA found Ardil Comercial's Limar hand sanitizer contained less isopropyl alcohol and undeclared ethanol and was packaged like a water bottle.

What happened

FDA tested a batch of Alcohol Isopropilico Hand Sanitizer Limar detained at the U.S. border and found it averaged 48% isopropyl alcohol instead of the labeled 70%, plus 16% undeclared ethanol. FDA held teleconferences with the firm on February 23 and June 16, 2021, and later said responses about CGMP operations and testing were inadequate. The firm recalled one lot after FDA warned the bottle resembled a water bottle.

What FDA found

  1. FDA lab testing found the hand sanitizer's labeled active ingredient, isopropyl alcohol, was partly replaced with undeclared ethanol.

    section 501(d)(2) of the FD&C Act, 21 U.S.C. 351(d)(2)
  2. FDA said the substitution showed the firm's quality assurance was not working under CGMP, and the firm did not provide adequate test methods for incoming isopropyl alcohol or finished product.

    section 501(a)(2)(B) of the FD&C Act, 21 U.S.C. 351(a)(2)(B); 21 CFR 211.84 and 211.165
  3. The product is an unapproved new drug because it is not generally recognized as safe and effective and has no FDA-approved application.

    section 505(a) of the FD&C Act, 21 U.S.C. 355(a)
  4. The label says 70% isopropyl alcohol but testing found less and found undeclared ethanol, so the labeling is false or misleading.

    section 502(a) of the FD&C Act, 21 U.S.C. 352(a)
  5. The container resembles a drinking water bottle, which FDA says can mislead adults and children into thinking the hand sanitizer is drinkable.

    section 502(i)(1) of the FD&C Act, 21 U.S.C. 352(i)(1)
  6. The label lacks a domestic address or telephone number for reporting serious adverse events.

    section 502(x) of the FD&C Act, 21 U.S.C. 352(x)

What FDA wants

FDA asks Ardil to respond in writing within 15 working days with an updated investigation, lists of raw materials and suppliers, all hand sanitizer batches shipped to the U.S., batch records, and a commitment to test every isopropyl alcohol and ethanol lot for methanol. FDA also recommends a qualified CGMP consultant if the firm wants to resume making drugs for the U.S. market.

Who should pay attention

  • brands and distributors that buy hand sanitizer from foreign manufacturers
  • retailers and importers of consumer antiseptic products
  • quality teams managing supplier verification and label review

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Ocean Group Inc.

    FDA found Listeria monocytogenes and seafood HACCP sanitation violations at Ocean Group's ready-to-eat salmon and tuna facilities.

    High risk
  2. DeVere Manufacturing Inc.

    FDA warned DeVere Manufacturing in Janesville, Wisconsin, that its OTC hand sanitizers are adulterated after a June 2025 inspection found CGMP failures.

    High risk
  3. CDL Services, Inc. DBA Technichem

    FDA warned CDL Services (Technichem), an Anaheim OTC drug maker, that it released hand sanitizer and hand soap batches without testing.

    High risk
  4. Naturich Cosmetique Labs

    FDA warned Naturich Cosmetique Labs over inadequate manufacturing controls for over-the-counter topical drugs, including contaminated water and untested ingredients.

    High risk